Stock Activity Watchlist: QEP Resources (NYSE:QEP), Mastercard Inc (NYSE:MA), Microsoft Corporation (NASDAQ:MSFT), FedEx Corporation (NYSE:FDX), Spectrum Pharmaceuticals (NASDAQ:SPPI)

QEP Resources, Inc. (NYSE:QEP) shares decreased -0.91% in last trading session and ended the day at $13.12. QEP Gross Margin is 56.40% and its has a return on assets of 7.70%. QEP Resources, Inc. (NYSE:QEP) quarterly performance is -29.74%.

QEP Resources, Inc. (NYSE:QEP) is a leading independent natural gas and crude oil exploration and production company focused in two major regions: the Northern Region (primarily the Rockies and the Williston Basin) and the Southern Region (primarily Texas and Louisiana) of the United States.

QEP Resources, Inc. (NYSE:QEP) announced that members of the Company’s senior management will participate in the upcoming Barclays CEO Energy/Power Conference on Thursday, September 10, 2015 at 9:05 a.m. EDT (7:05 a.m. MDT).

Mastercard Inc (NYSE:MA) shares moved up 2.62% in last trading session and ended the day at $92.90. MA has a return on assets of 25.10%. Mastercard Inc (NYSE:MA) quarterly performance is 1.05%.

MasterCard (NYSE: MA), www.mastercard.com, is a technology company in the global payments industry. We operate the world’s fastest payments processing network, connecting consumers, financial institutions, merchants, governments and businesses in more than 210 countries and territories.

In support of its Digital Enablement Express program launched earlier, Mastercard Inc (NYSE:MA) announced that Samsung has joined Express as one of the program’s first partners. Express expedites the process of digitizing and tokenizing MasterCard accounts – giving issuers the immediate ability to participate in Samsung Pay and enabling Samsung to bring secure mobile payments to consumers more quickly, and at scale.

Microsoft Corporation (NASDAQ:MSFT) caters to the Technology space. It has a net profit margin of 13.00% and weekly performance is 0.85%. On the last day of trading company shares ended up $43.89. Microsoft Corporation (NASDAQ:MSFT) distance from 50-day simple moving average (SMA50) is -2.61%.

Microsoft Corp. (MSFT) and Dell announced an expanded partnership to deliver premium Windows 10 devices and services and support to enterprise customers. Windows 10 will roll out new enterprise capabilities this month following a strong first month of availability with 75 million devices already running Windows 10.
Microsoft Corporation is engaged in developing, licensing and supporting a range of software products and services. The Company also designs and sells hardware, and delivers online advertising to the customers. The Company operates in five segments: Devices and Consumer (D&C) Licensing, D&C Hardware, D&C Other, Commercial Licensing, and Commercial Other.

On 08 September, FedEx Corporation (NYSE:FDX) shares increased 3.15% and was closed at $153.29. FDX EPS growth in last 5 year was -0.60%. FedEx Corporation (NYSE:FDX) year to date (YTD) performance is -11.51%.

FedEx Corporation (FedEx) provides a portfolio of transportation, e-commerce and business services under the FedEx brand. The Company offers its services through companies constituting four business segments: FedEx Express, FedEx Ground, FedEx Freight and FedEx Services. FedEx Express offers a range of domestic and international shipping services for delivery of packages and freight.

FedEx (NYSE:FDX) has earned a “BBB+” credit rating from analysts at Morningstar. The investment research firm’s “BBB+” rating indicates that the company is a moderate default risk. They also gave their stock a four star rating.

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) shares increased 1.91% in last trading session and ended the day at $6.40. SPPI Gross Margin is 84.90% and its has a return on assets of -8.80%. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) quarterly performance is -3.76%.

Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in Hematology and Oncology. Spectrum currently markets five hematology/oncology drugs, and expects an FDA decision on another hematology drug later this year.

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) announced that an overview of the Company’s business strategy and commercial and development-stage programs will be given at the Rodman & Renshaw 17th Annual Global Investment Conference being held at the St. Regis Hotel in New York City. The Company presentation is on Thursday, September 10, 2015, at 9:35 AM ET.